期刊文献+

姜黄素对大鼠肝星状细胞中TGF-β调节的NADPH氧化酶4的激活及Smad信号通路的影响 被引量:4

Curcumin attenuates hepatic fibrogenesis through interrupting TGF-β-mediated NADPH oxidase 4 activation and Smad signaling in vitro
下载PDF
导出
摘要 目的研究姜黄素潜在的抗纤维化作用,以及转化生长因子β(TGF-β)诱导大鼠肝星状细胞(HSC-T6)激活的机制。方法不同浓度的姜黄素(0、5、10、20、40μmol/L)处理HSC-T6后,用MTT法测定其对HSC-T6增殖作用的影响;用RT-PCR法检测其mRNA水平的表达;用Westem blot法检测表达α-平滑肌肌动蛋白(α-SMA)、细胞外基质主要成分α1I胶原(Col1α1)、NADPH氧化酶4(NOX 4)、Smad 2、Smad 3及其磷酸化的水平。结果 40μmol/L的姜黄素组刺激HSC-T6 48 h后,其抑制率达到最大,显著低于仅TGF-β1刺激组、5、10及20μmol/L姜黄素组(P<0.05)。姜黄素可显著降低激活型HSC-T6的α-SMA、α1I胶原mRNA与蛋白表达,从而可以降低细胞外基质的沉积;有效降低了NOX 4的蛋白水平,减少了活性氧的水平;还明显降低Smad2、Smad 3的磷酸化程度,呈浓度依赖性。结论姜黄素在体外能够明显地抑制HSC-T6激活,对肝纤维化的发生发展具有一定抑制作用,其机制可能与抑制TGF-β诱导的NOX4的激活及Smad信号通路有关。 Objective To observe the effects of curcumin on activation and proliferation of hepatic stellate cells (HSCs) and, their expression of NADPH oxidase 4 (NOX 4) and smad signaling factors of rat hepatic stellate cells line in vitro using a rat HSC line. Methods Synchronized HSC-T6 cells were treated with different dose of purified curcumin (0, 5, 10, 20, 40μmol/L). Untreated cells were viewed as controls. MTT technique analysis was used to examine the proliferation of the hepatic stellate cells stimulated by differernt concentration of curcumin;the mR-NA expression ofα-smooth muscle actin (α-SMA) and main constituents in extracellular matrix I procollagen (α1I collagen) were determined by RT-PCR in TGF-β-stimulated HSCs, and the antifibrotic effects on the protein ex-pression of α-SMA, α1I collagen, NADPH oxidase (NOX) protein (NOX 4) and the phosphorylation level of smad 2 and smad 3 was assessd by western blot;beta-actin (β-actin) was detected as the normalization control in the hepatic smllate cells was examined by Western blot analysis. Results The inhibition rate of HSC-T6 cells was the largest with curcumin for 48 h, significantly lower than that of TGF-β-stimulated group, 5 μmol/L, 10 μmol/L and 20 μmol/L group (P 〈0. 05). Notably, curcumin could obviously reduce the expression ofα-SMA andα1I collagen at both mRNA and protein levels and reduce the deposition of extracellular matrix. Treatment of curcumin markedly blocks up-regulation of NOX4 by TGF-β. It also significantly reduced TGF-β-induced Smad 2/3 phos-phorylation, and this effect observed dose-dependent. Conclusion Curcumin inhibited TGF-β-mediated HSC acti-vation in vitro, which was involved in Smad signaling pathway, and consequently influenced the profibrotic actions of TGF-β on HSC-T6 cells. Our results suggest that curcumin could become potential candidate for the therapeutic applications by inhibiting the TGF-β induced NOX activation and Smad signaling.
出处 《安徽医科大学学报》 CAS 北大核心 2015年第3期319-323,共5页 Acta Universitatis Medicinalis Anhui
基金 国家自然科学基金(编号:81273526)
关键词 姜黄素 大鼠肝星状细胞 转化生长因子Β NADPH氧化酶4 SMAD蛋白 curcumin rat hepatic stellate cell transforming growth factor-β NADPH oxidase 4 drosophilamothers against decapentaplegic protein
  • 相关文献

参考文献13

  • 1Koller T, Kollerova J, Huorka M, et al. Noninvasive scoring algo- rithm to identify significant liver fibrosis among treatment-naive chronic hepatitis C patients [ J]. Eur J Gastroenterol Hepatol,2014, 26(10): 1108-15.
  • 2Fnehs B C, ttoshida Y, Fujii T, et al. Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hep- atoeellular carcinoma [ J ]. Hepatology, 2014, 59 (4) : 1577 - 90.
  • 3邓燕红,沈能,凌宁,胡鹏,任红,唐华东,彭明利.姜黄素衍生物对四氯化碳诱导肝纤维化的治疗作用[J].中国临床药理学与治疗学,2012,17(2):147-153. 被引量:8
  • 4Oelkmg C, Lange C M, Wenzel E, et al. Analysis of the tumori- cidal and anti-cachectic potential of curcumin [ J ]. Anticancer Res, 2014, 34(9) : 4781 -8.
  • 5Zhang F, Zhang Z, Chen L, el al. Curcumin attenuates angiogen-esis in liver fibrosis and inhibits angiogenic properties of hepatic stellate cells[J]. J Cell Mol Med, 2014, 18(7) : 1392 -406.
  • 6Zhang Z, Guo Y, Zhang S, et al. Curcumin modulates cannabi- noid receptors in liver fibrosis in vivo and inhibits extracellular ma- trix expression in hepatic steilate ceils by suppressing cannabinoid receptor type-1 in vitro[ J]. Eur J Pharmacol, 2013,721 ( 1 - 3) : 133 -40.
  • 7Vera-Ramirez L, P6rez-Lopez P, Varela-Lopez A, et al. Curcu- min and liver disease[ M]//Jos6 L. Quiles. Biofactors, 2013, 39 (1): 88-100.
  • 8Tobar N, Toyos M, Urra C, et al. C-Jun N terminal kinase modu- lates NOX-4 derived ROS production and myofibroblasts differenti- ation in human breast stremal cells[J]. BMC Cancer, 2014, ld (1) : 640.
  • 9Presser L D, McRae S, Waris G. Activation of TGF-betal promot- er by hepatitis C virus-induced AP-1 and Spl : role of TGF-betal in hepatic stellate cell activation and invasion [ J ]. PLoS One,2013, 8(2):e56367.
  • 10Ding Z Y, Jin G N, Liang H F, et al. Transforming growth factor beta induces expression of connective tissue growth factor in hepat- ic progenitor cells through Smad independent signaling [ J ]. Cell Signal, 2013, 25(10) : 1981 -92.

二级参考文献14

  • 1Benyon R,Authur M.Extracellular matrix degrada-tion and the role of hepatic stellate cells[J].Semin Liver Dis,2001,21(3):373-384.
  • 2Jurenka J.Anti-inflammatory properties of curcu-min,a major constituent of curcuma longa:a review of preclinical and clinical research[J].Altern Med Rev,2009,14(2):141-153.
  • 3Vizzutti F,Provenzano A,Galastri S,et al.Curcumin limits the fibrogenic evolution of experimental steatohepatitis[J].Lab Invest,2010,90(1):104-115.
  • 4Reyes-Gordilloa K,Segovia J,Shibayama M,et al.Curcumin prevents and reverses cirrhosis induced by bile duct obstruction or CCl 4 in rats:role of TGF-b modulation and oxidative stress[J].Fund Clin Phar-macol,2008,12(4):417-427.
  • 5Solís-Herruzo J,Solís-Muoz P,Muoz-Yagüe T,et al.Molecular targets in the design of antifibrotic therapy in chronic liver disease[J].Rev Esp Enferm Dig,2011,103(6):310-323.
  • 6Ishak K,Baptista A,Bianchi L,et al.Histological grading and staging of chronic hepatitis[J].Hepa-tology,1995,22(6):696-699.
  • 7Livak K,Schmittgen T.Analysis of relative gene ex-pression data using realtime quantitative PCR and the2-G Method[J].Methods,2001,25(4):402-408.
  • 8Shankar T,Shantha NV,Ramesh HP,et al.Toxici-ty studies on turmeric(Curcuma longa):acute tox-icity studies in rats,guinea pigs and monkeys[J].Indian J Exp Biol,1980,18(1):73-75.
  • 9Wang YJ,Pan MH,Cheng AL,et al.Stability of curcumin in buffer solutions and characterization of its degradation products[J].Pharm Biomed Anal,1997,15(12):1867-1876.
  • 10Bisht S,Khanl MA,Bekhit M,et al.A polymeric nanoparticle formulation of curcumin(NanoCurct)ameliorates CCl 4-induced hepatic injury and fibrosis through reduction of pro-inflammator cytokines and stellate cell activation[J].Lab Invest,2011,91(9):1-13.

共引文献7

同被引文献122

引证文献4

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部